A detailed history of Clarius Group, LLC transactions in Twist Bioscience Corp stock. As of the latest transaction made, Clarius Group, LLC holds 49,635 shares of TWST stock, worth $2.07 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
49,635
Previous 49,635 -0.0%
Holding current value
$2.07 Million
Previous $2.45 Million 8.34%
% of portfolio
0.16%
Previous 0.18%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$14.6 - $30.9 $17,169 - $36,338
-1,176 Reduced 2.31%
49,635 $748,000
Q4 2022

Jan 25, 2023

BUY
$21.92 - $39.37 $25,777 - $46,299
1,176 Added 2.37%
50,811 $1.21 Million
Q2 2022

Aug 10, 2022

BUY
$26.2 - $54.0 $1.3 Million - $2.68 Million
49,635 New
49,635 $1.74 Million

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.35B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.